当前位置: X-MOL首页全球导师 国内导师 › 杜永丽

研究领域

主要从事药物化学、创新药物研究开发的研究工作。研究工作涉及药物化学、有机化学、计算机辅助药物设计、靶标大分子与药物相互作用的动力学模拟、生物活性评价等,是化学、生物、计算机辅助药物设计相互交叉融合的研究方向。

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

(1)Peihong Liu, Yongli Du*, Lianhua Song, Jingkang Shen, Qunyi Li, Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity, European Journal of Medicinal Chemistry, accepted, Available online 9 April 2016. (2)Yongli Du*, Hao Ling, Meng Zhang, Jingkang Shen, Qunyi Li, Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment– docking-oriented de novel design, Bioorganic & Medicinal Chemistry, 2015, 23: 4891-4898. (3)Peihong Liu, Yongli Du*, Lianhua Song, Jingkang Shen, Qunyi Li, Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methane -sulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic,Bioorganic & Medicinal Chemistry, 2015, 23: 7079-7088. (4)Yongli Du, Qunli Li, Bing Xiong, Xin Hui, Xin Wang, Yang Feng, Tao Meng, Dingyu Hu, Datong Zhang, Mingwei Wang, Jingkang Shen, Aromatic β-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists. Bioorganic & Medicinal Chemistry 2010, 18 (12), 4255- 4268. (5)Yongli Du, Qunyi Li, Bing Xiong, Xin Wang, Tao Meng, Dingyu Hu, Mingwei Wang, Jingkang Shen, The Discovery of Novel Non-steroidal Progesterone Receptor Antagonists. Abstract and poster on The 6th International Symposium for Chinese MedicinalChemists. 07. 2008. 2008年07月于第六届世界华人药物化学会议上获奖:The presentation of Yongli Du, Qunyi Li et al entitled The Discovery of NovelNon-steroidal Progesterone Receptor Antagonists has achieved Poster Presentation Award of The 6th International Symposium for Chinese Medicinal Chemists. (6)杜永丽,李群益,沈竞康,刘培红,新型取代磺酰胺类化合物、制备方法及其作为PTP1B抑制剂的用途,中国专利,CN2015104122426。 (7)杜永丽,沈竞康,李群益,凌浩,新型脲类蛋白酪氨酸磷酸酯酶1B抑制剂及其制备方法、药物组合物和用途,中国专利,CN2015102588258。 (8)杜永丽,沈竞康,李群益,刘培红,新型磺酰胺类化合物、制备方法及其作为蛋白酪氨酸磷酸酯酶1B抑制剂的用途,中国专利,CN2015104140693。

推荐链接
down
wechat
bug